Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Licenses Linear RNA Amplification Technology to Ambion

NEW YORK, Feb. 15-Ambion has established a non-exclusive license from Incyte Genomics to manufacture and sell kits based on linear RNA amplification technology, the companies said today.


The firms did not disclose the financial terms of the agreement.


Linear RNA amplification technology is an antisense method that increases cellular RNA expression in order to reveal gene expression patterns. This particular technique uses a series of enzymatic reactions to amplify small amounts of RNA, a process that may create a more accurate portrait of relative mRNA ratios.


Ambion's aRNA kit is capable of 1,000x RNA amplification, according to the company. A 20-reaction kit retails in the United States for $795.


The company has been selling the kit since last fall, said Ambion president Bruce Leander, and sales have been "absolutely fantastic."


"RNA amplification is a hot area," he said. "Researchers are very interested in expression and regulation, and the ability to amplify RNA is increasingly important."


Ambion, a privately held company that specializes in RNA products and technologies, is based in Austin, Tex.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.